FindTrial
Sign In

Efficacy of mesalazine in the long term prevention of diverticulitis relapses. Randomised study, double blind, controlled vs placebo.

Efficacy of mesalazine in the long term prevention of diverticulitis relapses. Randomised study, double blind, controlled vs placebo.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001459-39-IT
Enrollment
Unknown
Registered
2005-08-24
Start date
2005-05-12
Completion date
Unknown
Last updated
2013-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of diverticulitis relapses MedDRA version: 14.1 Level: LLT Classification code 10013540 Term: Diverticulitis intestinal System Organ Class: 100000004862

Interventions

Trade Name: PENTACOL 800*60CPR 800MG R.M. Pharmaceutical Form: Modified-release tablet INN or Proposed INN: Mesalazine CAS Number: 89-57-6 Concentration unit: mg milligram(s) Concentration number: 800

Sponsors

SOFAR SPA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026